Certificate Under Regulation 74(5) of SEBI(Depository and Participant) Regulation, 2018 for the Quarter Ended 31 December 2024.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 27 2024
- Closure of Trading Window
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 04 2024
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 03 2024
Later from Welcure Drugs and Pharmaceuticals
- Statement Of Investor Grievances Under Regulation 13(3) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015.
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jan 10 2025
- Submission Of SDD Compliance Certificate Under Regulation 3(5) And 3(6) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 For The Quarter Ended December 31St, 2024.
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jan 21 2025
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Wednesday, 22Nd January, 2025
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals